Navigation Links
GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
Date:10/29/2010

t attack and stroke.

It is currently estimated that Fabry disease affects approximately 5,000 to 10,000 people worldwide.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com

Amicus TherapeuticsAmicus Therapeutics is a biopharmaceutical company focused on developing treatments for rare diseases.  The Company is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and CNS diseases.  Amicus' lead program is in Phase 3 for the treatment of Fabry disease.  For further information, please visit www.amicustherapeutics.com.Amicus Enquiries:Analyst/Investor and Media enquiries:

Jenene Thomas

(609) 662-5084GlaxoSmithKline Enquiries:UK Media enquiries:

David Mawdsley

(020) 8047 5502Claire Brough

(020) 8047 5502Stephen Rea

(020) 8047 5502Alexandra Harrison

(020) 8047 5502Jo Revill

(020) 8047 5502US Media enquiries:

Nancy Pekarek

(919) 483 2839Mary Anne Rhyne

(919) 483 2839Kevin Colgan

(919) 483 2839Sarah Alspach

(919) 483 2839European Analyst/Investor enquiries:

Sally Ferguson

(020) 8047 5543Gary Davies

(020) 8047 5503US Analyst/ Investor enquiries:

Tom Curry

(215) 751 5419Jen Hill Baxter

(215) 751 7002Amicus Forward-Looking Statements This press release contains, and the accompanying conference call will contain, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 relating to preclinical and clinical d
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  Northwest Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), a ... and inoperable solid tumor cancers, announced today that CEO ... Annual Phacilitate Immunotherapy Forum in Washington D.C. ... place on January 26 at 10:30 a.m. EST at the ...
(Date:1/23/2015)... More than a third of reproductive-aged women enrolled in Medicaid, ... filled a prescription for an opioid pain medication each year ... and Mortality Weekly Report (MMWR). Opioids are ... severe pain.  They are also found in some prescription cough ...
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ... directors of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... breached its fiduciary duties to shareholders. On ... investing website reporting that Advaxis had misrepresented the clinical ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... BETHLEHEM, Pa., March 5, 2012 Particle Sciences, Inc. ... Inc. (LTI), a drug delivery technology company, announced ... rights to Lyotropic,s LyoCell® patent portfolio.  The LyoCell ... of a wide range of compounds - both small ...
... March 5, 2012  Chimerix, Inc., a biotechnology company developing ... President and Chief Executive Officer, will present at Cowen ... March 6, 2012 at 3:00 pm ET at The ... Mr. Moch,s presentation will include an update on the ...
Cached Medicine Technology:Particle Sciences Acquires Exclusive License to Lyotropic Therapeutics' Drug Delivery Technology 2Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference 2Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference 3
(Date:1/22/2015)... January 22, 2015 The Incredible Bulk is ... Pakulski to increase lean muscle by up to 30lbs in ... the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. ... is a step-by-step, scientific diet formula that allows the body ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... A new white paper by The ... in the long-term care environment as well as provides ... The paper, “The Power of Person-Centeredness in Long-Term Care: ... of the patient, resident and family experience in long-term ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 For over 20 years, ... Oceanside and Vista area has treated just about every ... personal injury circumstances. And for those same twenty-plus years, the ... of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... To protect ... brokerage firm that protects nearly 10,000 Alaskans each year with its fully insured membership program, ... ... , a brokerage firm which protects nearly 10,000 Alaskans each year against the high ...
... ... which debuted spring semester, integrate women’s psychology and relational-cultural theory to help students work ... ... help students enhance their emotional regulation skills, learn to problem solve and build stronger ...
... , ... ... , , , ... ...
... of preterm birth and stillbirthand what can be done to decrease ... year. Newborn deaths now account for more than 42 percent of ... 37 percent in the year 2000. Additionally, an estimated 3.2 ... linked to maternal deaths. The Global Report on ...
... ... ... ... ...
... ... has announced its official launch. , ... Anaheim, CA (Vocus) February 18, 2010 -- After a busy and ... The pilot ramp-up period was designed to simultaneously test its first product and the ...
Cached Medicine News:Health News:New Insurance Membership Program Protects Washington State Families Against High Cost of Emergency Medical Transports 2Health News:Bromley Brook Boarding School for Girls Creates Focus Cards to Help Students Regulate Emotions, Solve Problems 2Health News:Bromley Brook Boarding School for Girls Creates Focus Cards to Help Students Regulate Emotions, Solve Problems 3Health News:Court Orders Reinstatement of Vital, Cost-Saving Treatment for Children With Autism 2Health News:Court Orders Reinstatement of Vital, Cost-Saving Treatment for Children With Autism 3Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 2Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 3Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 4Health News:Experts call for acceleration of research and interventions for prematurity and stillbirth 5Health News:GREENGUARD Environmental Institute Revamps Web Site 2Health News:GREENGUARD Environmental Institute Revamps Web Site 3Health News:GREENGUARD Environmental Institute Revamps Web Site 4Health News:GREENGUARD Environmental Institute Revamps Web Site 5Health News:GREENGUARD Environmental Institute Revamps Web Site 6Health News:GREENGUARD Environmental Institute Revamps Web Site 7Health News:National Launch of Jusuru International 2Health News:National Launch of Jusuru International 3
... Independent controls for Digital Thermostat and Digital ... Anodized aluminum ends. , Interiorwhite anodized ... , Oversized refrigeration (134A). , ... Positive seal self-closing doors. , Foamed-in-place ...
... F340 is a basic laboratory system for ... results can be obtained when used with ... electrode. • Fast and easy one and ... for five buffers (pH 1.68, 4.00, 7.00, ...
... The DTX Series Multimode Detectors provide ... variety of application and automation needs. ... absorbance measurements on the same instrument, ... standalone instruments or can be integrated ...
... Screening (HTS), Analyst HT smoothes the ... sharing all the detection modalities and ... intensity, fluorescence polarization, time-resolved fluorescence, luminescence, ... into robotic environments, including those from ...
Medicine Products: